NCT06005714View on ClinicalTrials.gov

Effect of Pharmacokinetics in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
Interventions
DRUG

Mindeudesivir hydrobromide tablets and Clarithromycin tablets

Mindeudesivir hydrobromide tablets are administered once at D1 and D4, and clarithromycin tablets are administered twice from D1 to D10.

DRUG

Mindeudesivir hydrobromide tablets and Cyclosporine softgels

Mindeudesivir hydrobromide tablets are administered once at D1 and D4, and cyclosporine sofgels are administered once at D4.

Trial Locations (1)

450000

Zhengzhou Sixth People's Hospital, Zhengzhou

All Listed Sponsors
lead

Shanghai Vinnerna Biosciences Co., Ltd.

INDUSTRY